Insuman Comb 25 Solostar

Insulin Human, the active ingredient in Insuman Comb 25 Solostar, is an insulin presented as a premixed insulin solution for subcutaneous injection use. It treats diabetes mellitus in both type 1 and type 2 patients by providing basal and rapid‑acting glucose control.

GNH USA supplies Insuman Comb 25 Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 25 Solostar, a premixed human insulin, is used to manage blood glucose in diabetes mellitus.

- Type 1 diabetes mellitus: provides basal and prandial insulin to control fasting and post‑meal glucose levels. - Type 2 diabetes mellitus: adds insulin coverage when oral agents are insufficient, offering combined basal and rapid‑acting action. - Insulin‑deficient hyperglycemia: reduces elevated blood glucose during acute illness or stress in patients lacking adequate endogenous insulin.

Insuman Comb 25 Solostar may cause a range of adverse reactions.

Common Side Effects: - Hypoglycemia: low blood sugar episodes, especially if meals are missed or dosing is excessive. - Injection site pain or erythema: mild discomfort or redness at the injection site. - Weight gain: increase in body weight due to improved glucose utilization. - Lipodystrophy: localized changes in fat tissue at injection sites.

Serious or Rare Side Effects: - Severe hypoglycemia: profound low blood sugar that can lead to seizures or loss of consciousness. - Anaphylactic reaction: rare systemic allergic response requiring immediate medical attention. - Insulin antibody formation: immune response that may alter insulin effectiveness.

When using Insuman Comb 25 Solostar, several safety considerations are recommended.

- Blood glucose monitoring: check levels regularly to adjust dose and avoid hypoglycemia. - Dose adjustment during illness: increase monitoring and possibly dose when infection or stress raises glucose. - Avoid use in active hypoglycemia: do not administer if the patient is already experiencing low blood sugar. - Renal impairment caution: reduced clearance may require dose modification. - Pregnancy and lactation: safety data are limited; use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the pen.

Insuman Comb 25 Solostar can interact with other medications, affecting glucose control.

Major Interactions (Avoid): - Sulfonylureas: combined effect may cause severe hypoglycemia. - Meglitinides: additive glucose‑lowering effect increases hypoglycemia risk. - GLP‑1 receptor agonists: potentiate insulin action, heightening hypoglycemia potential.

Moderate Interactions (Monitor Closely): - Corticosteroids: may raise blood glucose, requiring dose adjustments. - Thiazide diuretics: can increase glucose levels, necessitating closer monitoring. - ACE inhibitors: may enhance insulin sensitivity, potentially leading to lower glucose readings.